论文部分内容阅读
近日,据耶鲁大学医学院的研究人员发表在神经学期刊上的报告称,一种实验性的抗癌药物能使脑细胞之间互相连接,促使阿尔茨海默氏症小鼠模型恢复记忆。该药物名为AZD05030,该药由阿斯利康公司研发,它在实体肿瘤的治疗中作用不明显,但似乎可阻止触发β-淀粉样斑块形成时造成的损害,这是阿尔茨海默氏症的一个特征。新的一项研究是由美国国家卫生研究院(NIH)创新工程支持的,用来测试试验失败药物对不同疾病的效果,其中包含测试AZD05030对阿尔茨海默氏症患者疗效的相关
Recently, according to a report published in the Journal of Neurology by researchers at Yale University School of Medicine, an experimental anti-cancer drug can connect brain cells to each other and promote recovery of memory in a mouse model of Alzheimer’s disease. The drug, AZD05030, developed by AstraZeneca, does not play a role in the treatment of solid tumors but appears to prevent the damage that triggers the formation of [beta] -amyloid plaques, which is caused by Alzheimer’s disease A characteristic of the disease. A new study, supported by the National Institutes of Health (NIH) Innovative Engineering, was used to test the effect of failed drugs on various diseases, including the test that measures the efficacy of AZD05030 in patients with Alzheimer’s disease